Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M70,514Revenue $M7,238Net Margin (%)18.5Z-Score11.0
Enterprise Value $M68,481EPS $5.0Operating Margin %26.2F-Score7
P/E(ttm))54.8Cash Flow Per Share $4.6Pre-tax Margin (%)25.6Higher ROA y-yY
Price/Book9.810-y EBITDA Growth Rate %26.0Quick Ratio3.7Cash flow > EarningsY
Price/Sales9.95-y EBITDA Growth Rate %17.5Current Ratio3.9Lower Leverage y-yY
Price/Cash Flow20.1y-y EBITDA Growth Rate %1.9ROA % (ttm)12.0Higher Current Ratio y-yN
Dividend Yield %0.1Insider Buy (3m)0ROE % (ttm)19.7Less Shares Outstanding y-yN
Payout Ratio %4.0Shares Outstanding M298ROI % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNGeorge Soros 2014-12-31 Buy 1.1%$176.86 - $214
($199.35)
$ 234.8618%New holding, 494786 sh.494,786
AGNJohn Paulson 2014-12-31 Add1.09%$176.86 - $214
($199.35)
$ 234.8618%Add 18.46%6,370,000
AGNDaniel Loeb 2014-12-31 Buy 0.77%$176.86 - $214
($199.09)
$ 234.8618%New holding, 400000 sh.400,000
AGNJean-Marie Eveillard 2014-12-31 Add0.32%$176.86 - $214
($199.09)
$ 234.8618%Add 6244.76%634,476
AGNBill Ackman 2014-12-31 Reduce-2.98%$176.86 - $214
($199.35)
$ 234.8618%Reduce -7.77%26,635,978
AGNAndreas Halvorsen 2014-12-31 Reduce-0.22%$176.86 - $214
($199.35)
$ 234.8618%Reduce -13.76%1,966,112
AGNMario Gabelli 2014-12-31 Reduce-0.05%$176.86 - $214
($199.09)
$ 234.8618%Reduce -43.7%69,780
AGNJoel Greenblatt 2014-12-31 Reduce-0.01%$176.86 - $214
($199.35)
$ 234.8618%Reduce -83.33%945
AGNAndreas Halvorsen 2014-09-30 Add1.04%$151.92 - $179.7
($165.84)
$ 234.8642%Add 183.77%2,279,736
AGNRichard Perry 2014-09-30 Sold Out -7.8%$151.92 - $179.7
($165.84)
$ 234.8642%Sold Out0
AGNJohn Paulson 2014-09-30 Reduce-0.16%$151.92 - $179.7
($165.84)
$ 234.8642%Reduce -4.01%5,377,200
AGNJoel Greenblatt 2014-09-30 Reduce-0.02%$151.92 - $179.7
($165.84)
$ 234.8642%Reduce -65.17%5,670
AGNJean-Marie Eveillard 2014-09-30 Reduce-0.01%$151.92 - $179.7
($165.84)
$ 234.8642%Reduce -66.67%10,000
AGNBill Ackman 2014-06-30 Add38%$116.63 - $173.95
($155.63)
$ 234.8651%Add 4733.79%28,878,538
AGNRichard Perry 2014-06-30 Buy 7.8%$116.63 - $173.95
($155.63)
$ 234.8651%New holding, 1667625 sh.1,667,625
AGNJohn Paulson 2014-06-30 Buy 4.1%$116.63 - $173.95
($155.63)
$ 234.8651%New holding, 5602000 sh.5,602,000
AGNAndreas Halvorsen 2014-06-30 Buy 0.59%$116.63 - $173.95
($155.63)
$ 234.8651%New holding, 803369 sh.803,369
AGNJean-Marie Eveillard 2014-06-30 Buy 0.01%$116.63 - $173.95
($155.63)
$ 234.8651%New holding, 30000 sh.30,000
AGNRay Dalio 2014-06-30 Sold Out -0.02%$116.63 - $173.95
($155.63)
$ 234.8651%Sold Out0
AGNBill Ackman 2014-03-31 Buy 0.88%$110.28 - $131.43
($121.38)
$ 234.8694%New holding, 597431 sh.597,431
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AGN Daniel Loeb 2014-12-31400,0000.130.77New Buy
AGN George Soros 2014-12-31494,7860.171.1New Buy
AGN Jean-Marie Eveillard 2014-12-31634,4760.210.33+6244.76%
AGN John Paulson 2014-12-316,370,0002.147+18.46%
AGN Dodge & Cox 2014-12-313,26400
AGN Ken Fisher 2014-12-315,97200-0.71%
AGN Bill Ackman 2014-12-3126,635,9788.9435.3-7.77%
AGN Andreas Halvorsen 2014-12-311,966,1120.661.9-13.76%
AGN Mario Gabelli 2014-12-3169,7800.020.08-43.7%
AGN Joel Greenblatt 2014-12-3194500-83.33%
Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$0view
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8249.36view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.785.16view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7985.02view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3584.2view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3984.14view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6683.75view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7485.1view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.487.09view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5288.42view

Press Releases about AGN :

    Quarterly/Annual Reports about AGN:

    News about AGN:

    Articles On GuruFocus.com
    Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 
    Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC Feb 22 2015 
    John Paulson's Top Buys Feb 21 2015 
    A Look at Larry Robbins and His Latest Portfolio Update Feb 20 2015 
    Aegean Metals Group Inc. Announces Closing of Arrangement Jan 16 2015 
    Aegean Commences Drilling at Hot Maden Gold-Copper Project, Eastern Turkey Dec 15 2014 
    Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
    Guru Bill Ackman Is Having a Very Good Year Nov 10 2014 
    Aegean Metals Group & Mariana Resources Limited Sign Plan of Arrangement Nov 05 2014 
    Aegean Metals Group Inc. Closes Non-Brokered Private Placement with Lead Order Oct 23 2014 


    More From Other Websites
    Biotech Hedge Fund Deerfield Management’s Top Stock Picks Feb 28 2015
    FDA approves Allergan's Natrelle Inspira implants Feb 27 2015
    Rationale of the Salix–Valeant merger Feb 27 2015
    FDA Approves Allergan's NATRELLE INSPIRA™ Round Gel-Filled Breast Implants Feb 27 2015
    FDA Approves Allergan’s NATRELLE INSPIRA™ Round Gel-Filled Breast Implants Feb 27 2015
    Actavis' Infectious Disease Product, Avycaz, Gets FDA Nod - Analyst Blog Feb 26 2015
    ALLERGAN INC Financials Feb 25 2015
    Allergan: A new position for Glenview Capital Management Feb 25 2015
    Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog Feb 24 2015
    Allergan, Inc. (AGN), HCA Holdings Inc (HCA), Gilead Sciences, Inc. (GILD) Among Healthcare Stocks... Feb 24 2015
    Oclaro, Inc. (OCLR): Soros Fund Management’s Latest Acquisition and Other New Positions Feb 24 2015
    Allergan CEO May Get $100 Million for Getting Fired Feb 24 2015
    Allergan CEO May Get $100 Million If Terminated Following Buyout Feb 24 2015
    Nexvet Biopharma plc (NVET), Allergan, Inc. (AGN), DIRECTV (DTV) : Farallon Capital’s New Activist... Feb 23 2015
    Actavis Announces Proposed Public Offerings of Ordinary Shares and Mandatory Convertible Preferred... Feb 20 2015
    Billionaire Bill Ackman’s Top Picks: Allergan Inc. (AGN), Air Products & Chemicals Inc. (APD),... Feb 19 2015
    Allergan Still Looks Like a Trophy Worth Winning for Actavis Feb 19 2015
    Actavis (ACT) Earnings Report: Q4 2014 Conference Call Transcript Feb 19 2015
    Actavis Announces Intention to Adopt "Allergan" Corporate Name Feb 19 2015
    Pharmaceutical giant Actavis plans to rename itself Allergan Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK